ClinicalTrials.Veeva

Menu

Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCT (PRADEX)

A

Assistance Publique - Hôpitaux de Paris

Status and phase

Not yet enrolling
Phase 3

Conditions

X-linked Hypophosphatemia (XLH)

Treatments

Device: fluoride varnish
Device: adhesive system
Drug: flowable composite

Study type

Interventional

Funder types

Other

Identifiers

NCT04872907
APHP180575

Details and patient eligibility

About

This study is a prospective, randomized, single-blind, split-mouth, national multicenter trial, comparing the efficacy of a self-etch adhesive system combined (SAM) with a flowable composite to that of a fluoride varnish for the prevention of spontaneous dental abscesses in children with XLH. For each patient, according to randomization, one side of the oral cavity is treated with the experimental treatment (application of the adhesive system to healthy anterior and posterior temporary teeth, and application of the flowable composite to healthy posterior temporary teeth), and the other side with the active comparator (fluoride varnish). The application process for both treatments is similar and will be renewed every 6 months (visits at 6, 12, 18 and 24 months) systematically for the SAM and the varnish, and in case of partial or total loss of the composite.

Full description

X-linked hypophosphatemia (XLH) is a vitamin D-resistant familial rickets resulting from a mutation of the PHEX gene. One of the major clinical disorders is dental pulp necrosis, which results in "spontaneous" dental abscesses not related to carious lesions or trauma. These abscesses, which occur in about 67% of children with XLH, can lead to serious complications: loss of teeth, disorders of masticatory, phonetic and aesthetic functions, disorders of occlusion and alveolar-dental development, cervicofacial cellulitis, consequences on the psychological development of the child. this study is the first randomized controlled trial for the prevention of these abscesses.

Primary objective is to evaluate whether a non-invasive adhesive technique, combining the application of a self-etch adhesive system (SAM) to all faces (smooth, proximal and occlusal) of all temporary teeth (anterior and posterior) and a flowable composite applied in the grooves of the posterior temporary teeth, is effective in preventing the development of spontaneous abscesses in children with XLH, compared to the application of a fluoride varnish.

Enrollment

60 estimated patients

Sex

All

Ages

30 months to 8 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • X-linked hypophosphatemia diagnosed by the doctor specializing in the disease.
  • Patients with at least two healthy contralateral quadrants (right and left) at inclusion defined by the absence of symptomatic or asymptomatic spontaneous abscess, carious lesion and trauma (concussion, subluxation, dislocation, crack, fracture) on all teeth in the quadrant.

Exclusion criteria

  • Antibiotic treatment within 15 days prior to inclusion
  • Patients with a mental disability,
  • Patients with cancer, heart disease, sickle cell anemia, pathological bruxism
  • Patients with contraindications to study treatments

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

adhesive system + flowable composite
Experimental group
Description:
Side of the mouth randomlly assigned to this arm will receive self etch adhesive system and flowable composite combination on temporary molars and self etch adhesive system on anterior temporary teeth at baseline, M6, M12, M18
Treatment:
Drug: flowable composite
Device: adhesive system
Fluoride varnish
Active Comparator group
Description:
Side of the mouth randomly assigned to this arm will receive the fluride varnish at baseline, M6, M12, M18 on the temporary teeth
Treatment:
Device: fluoride varnish

Trial contacts and locations

0

Loading...

Central trial contact

Violaine Smail-Faugeron, DDS, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems